This is a fictional, illustrative case created for education. It is not medical advice, diagnosis, or treatment, and does not describe a real person.

She ovulated on paper. She still wasn't getting pregnant.

Ada, 40, had PCOS, a failed Clomid round, and labs that everyone said were improving. Her genetics helped explain why her ovaries responded differently — and gave her better questions for the next treatment conversation.

Persona

Ada, 40, Female, Nigerian British, Secondary school teacher.

Ada was diagnosed with PCOS two years ago after 14 months of trying to conceive with no success. She had irregular cycles ranging from 45 to 90 days and rarely ovulated without medication. One round of Clomid produced a large lead follicle but no confirmed pregnancy. She switched to letrozole, produced two follicles, but the cycle ended with a chemical pregnancy at 5 weeks. Her fertility specialist says her labs are 'going in the right direction.' Ada wants to understand why her ovaries respond unevenly and what her genetics might add to the conversation.

Family history: Mother: PCOS, conceived both children with fertility treatment. Maternal grandmother: type 2 diabetes at 55. No known miscarriage history on either side.

Clinical picture

Symptoms

Labs

Medications

Supplements

Lifestyle

Genetics

The follicles were there. The pregnancies weren't.

Ada did everything right by the standard checklist. She took her medication on the right days, came in for her monitoring scans, and watched the follicle grow on the ultrasound screen. She left feeling hopeful. The Clomid cycle produced nothing. The letrozole cycle produced a positive test that disappeared at five weeks. Her numbers were trending better, she was told. The plan was to try again. What she wanted was a better explanation for why the follicles that appeared on screen were not becoming the pregnancies she expected.

PCOS infertility is not one problem

PCOS-related infertility often gets simplified into 'she doesn't ovulate,' which is true but incomplete. The mechanisms that disrupt ovulation also affect egg quality, the hormonal environment around the follicle, the lining that receives a fertilized egg, and the early signaling of a new pregnancy. Ada's PCOS isn't just an ovulation problem. It's an LH problem, an insulin problem, a methylation problem, and possibly an early luteal phase problem — each one tugging at the others.

The LH:FSH ratio was the clue the ultrasound confirmed

Ada's LH was running more than three times her FSH — a ratio that reflects the hormonal imbalance underlying PCOS. High LH tells the ovaries to make more androgen and pushes the final maturation signal earlier than it should arrive. If her LHCGR receptor is also more sensitive to that already-elevated LH signal, the follicle can luteinize before the egg inside is ready to fertilize or implant. A large follicle on scan can look like success while the biology underneath has already moved past the window.

The chemical pregnancy pointed to the lining, not just the egg

A chemical pregnancy — a positive test that disappears before ultrasound confirmation — can mean the egg fertilized but the embryo couldn't implant or sustain itself. Ada's homocysteine is elevated, her B12 is suboptimal, and her MTHFR C/T result means folic acid conversion may be incomplete. Homocysteine has a direct effect on the endometrial environment in early implantation studies. Her prenatal vitamin contains folic acid, not methylfolate. The chemical pregnancy may be telling a story about the lining that the Clomid cycle — which ended without a pregnancy at all — never had the chance to tell.

Five conversations to have before the next cycle

Ada's pre-cycle preparation goal

Methylfolate + B12 + inositol protocol before next monitoring scan. Ada used the gap before her next scheduled cycle to address the modifiable methylation and insulin findings. Her goal was to arrive at the next scan with homocysteine trending down and a fuller pre-cycle baseline.